Search results
Results from the WOW.Com Content Network
Hyperandrogenism is a medical condition characterized by high levels of androgens.It is more common in women than men. [4] Symptoms of hyperandrogenism may include acne, seborrhea, hair loss on the scalp, increased body or facial hair, and infrequent or absent menstruation.
The healthcare needs of intersex people vary depending on which variations they have. Intersex conditions are diagnosed prenatally, at birth, or later in life via genetic and hormone testing as well as medical imaging. Intersex healthcare has historically focused on patients fitting physical and social norms for one's sex.
A member of the legal committee for the World Professional Association for Transgender Health and co-founder of the Australian and New Zealand Professional Association for Transgender Health has described "transsexualism" as "an intersex condition and a disorder of sexual development therapeutically medically treated by hormonal therapy and ...
The Society for Women's Health Research (SWHR) is a national non-profit organization based in Washington, D.C. SWHR is the thought leader in research on biological differences in disease and is dedicated to transforming women's health through science, advocacy, and education.
Currently, prenatal testing and hormone treatment to prevent the physical and behavioral expression of intersex traits is available. [17] [18] [19] In 1990, a paper by Heino Meyer-Bahlburg titled Will Prenatal Hormone Treatment Prevent Homosexuality? was published in the Journal of Child and Adolescent Psychopharmacology.
A 2009 MRI study by Luders et al. found that among 24 trans women not treated with hormone therapy, regional gray matter concentrations were more similar to those of cisgender men than of cisgender women, but there was a significantly greater volume of gray matter in the right putamen compared to cisgender men. Like earlier studies, researchers ...
"Providers are encouraged to consult with their local lab(s) to obtain hormone level reference ranges for both 'male' and 'female' norms, [which can vary,] and then apply the correct range when interpreting results based on the current hormonal sex, rather than the sex of registration." [3] Fenway Health: United States: 100–200 pg/mL <55 ng ...
Contraception is a major issue of women’s reproductive health. 86% of sexually active women practice some form of contraception and 30% of these women use a hormonal form of contraception. [10] Women in the U.S. have more freedoms in deciding their use of contraceptives among other global nations, comparatively.